| Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting J Huang, X Li, X Shi, M Zhu, J Wang, S Huang, X Huang, H Wang, L Li, ... Journal of hematology & oncology 12, 1-22, 2019 | 335 | 2019 |
| High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically … X Li, C Li, J Jin, J Wang, J Huang, Z Ma, X Huang, X He, Y Zhou, Y Xu, ... EBioMedicine 38, 47-56, 2018 | 68 | 2018 |
| Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development Y Yao, F Li, J Huang, J Jin, H Wang Experimental Hematology & Oncology 10 (1), 39, 2021 | 57 | 2021 |
| Effects of different shear rates on the attachment and detachment of platelet thrombi X Shi, J Yang, J Huang, Z Long, Z Ruan, B Xiao, X Xi Molecular Medicine Reports 13 (3), 2447-2456, 2016 | 46 | 2016 |
| Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study X Lin, J Wang, X Huang, H Wang, F Li, W Ye, S Huang, J Pan, Q Ling, ... Aging (Albany NY) 13 (7), 10468, 2021 | 42 | 2021 |
| Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia J Wang, W Ye, X Yan, Q Guo, Q Ma, F Lin, J Huang, J Jin Journal of translational medicine 17, 1-9, 2019 | 36 | 2019 |
| High expression of TET1 predicts poor survival in cytogenetically normal acute myeloid leukemia from two cohorts J Wang, F Li, Z Ma, M Yu, Q Guo, J Huang, W Yu, Y Wang, J Jin EBioMedicine 28, 90-96, 2018 | 35 | 2018 |
| Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine X Li, X Yan, W Guo, X Huang, J Huang, M Yu, Z Ma, Y Xu, SJ Huang, C Li, ... Biomedicine & Pharmacotherapy 90, 699-704, 2017 | 28 | 2017 |
| Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199 S Mao, Q Ling, J Pan, F Li, S Huang, W Ye, W Wei, X Lin, Y Qian, Y Wang, ... Journal of Translational Medicine 19 (1), 181, 2021 | 26 | 2021 |
| Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia X Lin, Q Ling, Y Lv, W Ye, J Huang, X Li, Q Guo, J Wang, Z Li, J Jin Cancer Biomarkers 28 (2), 151-158, 2020 | 25 | 2020 |
| Prognostic impact of MYH9 expression on patients with acute myeloid leukemia M Yu, J Wang, Z Zhu, C Hu, Q Ma, X Li, X Yin, J Huang, T Zhang, Z Ma, ... Oncotarget 8 (1), 156, 2016 | 25 | 2016 |
| The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia X Li, X Yin, H Wang, J Huang, M Yu, Z Ma, C Li, Y Zhou, X Yan, SJ Huang, ... Oncotarget 8 (8), 12764, 2017 | 20 | 2017 |
| Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia J Wang, M Yu, Q Guo, Q Ma, C Hu, Z Ma, X Yin, X Li, Y Wang, H Pan, ... Scientific Reports 7 (1), 45960, 2017 | 19 | 2017 |
| Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia S Huang, J Pan, J Jin, C Li, X Li, J Huang, X Huang, X Yan, F Li, M Yu, ... Cancer Letters 461, 132-143, 2019 | 18 | 2019 |
| Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy J Huang, X Shi, W Xi, P Liu, Z Long, X Xi Journal of Hematology & Oncology 8, 1-14, 2015 | 17 | 2015 |
| Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia W Wei, S Huang, Q Ling, S Mao, Y Qian, W Ye, F Li, J Pan, X Lin, J Huang, ... Journal of translational medicine 20 (1), 299, 2022 | 14 | 2022 |
| MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway Q Ling, F Li, X Zhang, S Mao, X Lin, J Pan, W Ye, W Wei, Y Qian, C Hu, ... EBioMedicine 69, 2021 | 14 | 2021 |
| Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases X Zhou, X Ye, Y Ren, C Mei, L Ma, J Huang, W Xu, J Wei, L Ye, W Mai, ... Frontiers of Medicine 10, 430-436, 2016 | 11 | 2016 |
| Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis F Li, W Ye, Y Yao, W Wei, X Lin, H Zhuang, C Li, X Li, Q Ling, C Hu, ... Journal of Translational Medicine 21 (1), 115, 2023 | 10 | 2023 |
| Ibrutinib suppresses early megakaryopoiesis but enhances proplatelet formation J Huang, S Huang, Z Ma, X Lin, X Li, X Huang, J Wang, W Ye, Y Li, D He, ... Thrombosis and Haemostasis 121 (02), 192-205, 2021 | 9 | 2021 |
